AI-generated summary
The authors used cDNA microarray analysis on buccal cell samples from patients receiving chemoradiotherapy for head and neck cancer, comparing those given oral photobiomodulation with controls. They report 105 upregulated and 60 downregulated genes, including genes linked to keratinocyte differentiation and to cytotoxicity and immune response. The authors suggest these gene changes may relate to the lower oral mucositis incidence seen clinically, but this is a small pilot study.
- Participants
- 27
- Who or what was studied
- Patients receiving chemoradiotherapy for head and neck squamous cell carcinoma who developed or were at risk of oral mucositis
- Limits stated in the abstract
- Small pilot study with 13 patients for microarray analysis and 14 for qPCR validation, and the abstract does not state the wavelengths used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Pilot study, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.